Adrienne Gropper Waks, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 34 | 2024 | 20824 | 2.110 |
Why?
|
Receptor, erbB-2 | 16 | 2024 | 2417 | 1.500 |
Why?
|
Neoadjuvant Therapy | 11 | 2023 | 2727 | 0.910 |
Why?
|
Receptors, Progesterone | 5 | 2021 | 1098 | 0.900 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2024 | 11525 | 0.630 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2023 | 3480 | 0.520 |
Why?
|
Pneumocystis carinii | 1 | 2015 | 74 | 0.510 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 577 | 0.510 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1038 | 0.490 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2015 | 249 | 0.470 |
Why?
|
Receptors, Estrogen | 6 | 2021 | 2190 | 0.440 |
Why?
|
Paclitaxel | 5 | 2023 | 1708 | 0.440 |
Why?
|
Opportunistic Infections | 1 | 2015 | 389 | 0.420 |
Why?
|
Cervix Uteri | 1 | 2015 | 590 | 0.390 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 484 | 0.380 |
Why?
|
Infertility | 1 | 2016 | 655 | 0.330 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13693 | 0.310 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3590 | 0.310 |
Why?
|
Female | 37 | 2024 | 380193 | 0.250 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4839 | 0.220 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2020 | 0.220 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2023 | 710 | 0.210 |
Why?
|
Taxoids | 2 | 2023 | 666 | 0.210 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2014 | 255 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5172 | 0.200 |
Why?
|
Suburban Population | 1 | 2011 | 55 | 0.200 |
Why?
|
Prospective Studies | 8 | 2023 | 53290 | 0.190 |
Why?
|
Fibroblast Growth Factor 3 | 1 | 2020 | 17 | 0.190 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1262 | 0.190 |
Why?
|
Filgrastim | 1 | 2020 | 133 | 0.180 |
Why?
|
Schistosoma haematobium | 1 | 2009 | 11 | 0.180 |
Why?
|
Schistosomiasis haematobia | 1 | 2009 | 15 | 0.180 |
Why?
|
Genomics | 4 | 2023 | 5717 | 0.180 |
Why?
|
Humans | 38 | 2024 | 744366 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2020 | 188 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 250 | 0.170 |
Why?
|
Schistosomiasis mansoni | 1 | 2009 | 85 | 0.170 |
Why?
|
Schistosoma mansoni | 1 | 2009 | 149 | 0.160 |
Why?
|
Genes, erbB-2 | 1 | 2019 | 162 | 0.160 |
Why?
|
Platinum | 1 | 2020 | 233 | 0.160 |
Why?
|
Aromatase Inhibitors | 2 | 2019 | 490 | 0.160 |
Why?
|
Germ Cells | 1 | 2022 | 631 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.160 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11031 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2012 | 545 | 0.140 |
Why?
|
RNA | 2 | 2024 | 2749 | 0.130 |
Why?
|
Pregnancy | 2 | 2016 | 29144 | 0.130 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 3 | 2020 | 5534 | 0.130 |
Why?
|
BRCA2 Protein | 1 | 2020 | 794 | 0.130 |
Why?
|
Prognosis | 4 | 2019 | 29060 | 0.130 |
Why?
|
Piperazines | 3 | 2020 | 2488 | 0.120 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1182 | 0.120 |
Why?
|
Gene Amplification | 1 | 2019 | 1063 | 0.120 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2242 | 0.120 |
Why?
|
Middle Aged | 14 | 2023 | 213390 | 0.120 |
Why?
|
Doxorubicin | 1 | 2020 | 2234 | 0.110 |
Why?
|
Survivors | 2 | 2016 | 2291 | 0.110 |
Why?
|
Pyridines | 3 | 2020 | 2825 | 0.110 |
Why?
|
Anthracyclines | 1 | 2015 | 288 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1149 | 0.110 |
Why?
|
Hepatitis C | 1 | 2023 | 1591 | 0.110 |
Why?
|
Amenorrhea | 1 | 2016 | 485 | 0.100 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1758 | 0.100 |
Why?
|
Adult | 11 | 2023 | 214052 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4851 | 0.090 |
Why?
|
Breast Neoplasms, Male | 1 | 2011 | 210 | 0.090 |
Why?
|
Zambia | 2 | 2011 | 261 | 0.090 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.090 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2016 | 1206 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3464 | 0.080 |
Why?
|
Mutation | 3 | 2023 | 29786 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9240 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2012 | 2736 | 0.080 |
Why?
|
Aged | 7 | 2023 | 163288 | 0.080 |
Why?
|
Communication | 1 | 2011 | 3750 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1856 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3922 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.070 |
Why?
|
Disease Management | 1 | 2015 | 2460 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.060 |
Why?
|
Methylene Blue | 1 | 2014 | 155 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5692 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2023 | 63107 | 0.050 |
Why?
|
Schools | 2 | 2011 | 1433 | 0.050 |
Why?
|
Coloring Agents | 1 | 2014 | 566 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10388 | 0.050 |
Why?
|
Premedication | 1 | 2021 | 258 | 0.050 |
Why?
|
Parotid Neoplasms | 1 | 2012 | 155 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12802 | 0.050 |
Why?
|
Axilla | 1 | 2023 | 597 | 0.050 |
Why?
|
Parasite Egg Count | 1 | 2009 | 27 | 0.050 |
Why?
|
Male | 8 | 2023 | 350115 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2020 | 98 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 2020 | 155 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 16690 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9955 | 0.040 |
Why?
|
Urine | 1 | 2009 | 370 | 0.040 |
Why?
|
Incidence | 1 | 2015 | 20952 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6896 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 323 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 539 | 0.030 |
Why?
|
HIV Infections | 1 | 2011 | 16715 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2924 | 0.030 |
Why?
|
Tamoxifen | 1 | 2018 | 981 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2024 | 2938 | 0.030 |
Why?
|
Breast | 1 | 2023 | 1970 | 0.030 |
Why?
|
HIV | 1 | 2011 | 1604 | 0.030 |
Why?
|
Age Distribution | 1 | 2009 | 2902 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1252 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1692 | 0.030 |
Why?
|
Risk Factors | 2 | 2015 | 72296 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3554 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 550 | 0.030 |
Why?
|
Estradiol | 1 | 2019 | 2020 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39052 | 0.030 |
Why?
|
Urban Population | 1 | 2009 | 2022 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 2504 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1862 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1524 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 1988 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5077 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4208 | 0.020 |
Why?
|
Caregivers | 1 | 2011 | 2095 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4185 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2024 | 13035 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6755 | 0.020 |
Why?
|
Child, Preschool | 2 | 2011 | 41005 | 0.020 |
Why?
|
Mastectomy | 1 | 2014 | 1793 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 19905 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2009 | 7785 | 0.020 |
Why?
|
Sex Factors | 1 | 2009 | 10400 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4222 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 16000 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8432 | 0.020 |
Why?
|
Software | 1 | 2017 | 4441 | 0.010 |
Why?
|
Prevalence | 1 | 2009 | 15221 | 0.010 |
Why?
|
Child | 2 | 2011 | 77709 | 0.010 |
Why?
|
Adolescent | 2 | 2011 | 85779 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25039 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2011 | 3395 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8319 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2011 | 3229 | 0.010 |
Why?
|
Anxiety | 1 | 2011 | 4293 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11126 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77460 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56429 | 0.010 |
Why?
|
Animals | 1 | 2009 | 168768 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2011 | 57776 | 0.000 |
Why?
|